Abstract
This systemic analysis was conducted to evaluate tumor recurrence rate and one-year survival rate for patients with liver metastases received radiofrequency ablation after transarterial chemoembolization and introduce a new method of radiofrequency ablation by puncture navigation technology for single liver metastases after transarterial chemoembolization. Clinical studies evaluating tumor recurrence rate and one-year survival rate. Appling the innova trackvision software to process one liver metastases received transarterial chemoembolization and using radiofrequency ablation by puncture navigation technology to treat the liver metastases. 3 clinical studies which including 235 patients with liver metastases after transaeterial chemoembolization were considered eligible for inclusion. Systemic analysis suggested that tumor recurrence rate was 23% (54/235), one-year survival rate was 76% (178/235). The new procedure was performed successfully and the patient received a good prognosis. This systemic analysis suggests that radiofrequency ablation is a good method for liver metastases after transarterial chemoembolization and could receive a relatively good prognosis.
Highlights
Liver metastases will develop at some point during the course of the disease in up to 50% of these patients with gastrointestinal tumors (Michael et al, 2014)
Survival of patients with hepatocellular carcinoma (HCC) and other liver metastases less than 3cm treated by Radiofrequency ablation (RFA) competes with that of surgical candidaties (Lupo et al, 2007; Germani et al, 2010; Lewandowski et al, 2011)
We hypothesize that RFA under puncture navigation technology (PNT) for Liver Metastases after Transarterial Chemoembolization could be established as an alternative treatment method
Summary
Liver metastases will develop at some point during the course of the disease in up to 50% of these patients with gastrointestinal tumors (Michael et al, 2014). We first do RFA under fluoroscopy puncture navigation technology (PNT) with the development of technology and introduce the process of this new treatment According to this background, we hypothesize that RFA under PNT for Liver Metastases after Transarterial Chemoembolization could be established as an alternative treatment method. We hypothesize that RFA under PNT for Liver Metastases after Transarterial Chemoembolization could be established as an alternative treatment method This systemic analysis was conducted to evaluate tumor recurrence rate and one-year survival rate for patients with liver metastases received radiofrequency ablation after transarterial chemoembolization and introduce a new method of radiofrequency ablation by puncture navigation technology for single liver metastases after transarterial chemoembolization. Conclusions: This systemic analysis suggests that radiofrequency ablation is a good method for liver metastases after transarterial chemoembolization and could receive a relatively good prognosis
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
